3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
7
Esophageal Squamous Cell Carcinoma
4
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Advanced Solid Tumor
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Advanced Breast Cancer
2
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Solid Tumor
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Papillomavirus Infections
1
Pancreatic Cancer Metastatic
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Muscle Invasive Bladder Cancer (MIBC)
1
Mouth Neoplasms
1
Meningeal Carcinomatosis
1
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
1
Interventions
Gemcitabine
10
Mitomycin
6
Docetaxel
5
erdafitinib
4
durvalumab
4
BCG Vaccine
4
dodecyl maltoside
3
Cystoscopy
3
ALT-803
2
viscum album peptide
1
tremelimumab
1
pirarubicin
1
monalizumab
1
hydroxycamptothecinum
1
chondroitin sulfate, sodium hyaluronate drug combination
1
Watchful Waiting
1
Transurethral Resection of Bladder
1
Patient Discharge
1
Mitozytrex
1
Magnetic Resonance Spectroscopy
1
Injections
1
Hyaluronic Acid
1
House Calls
1
Home Care Services
1
Epirubicin
1
Drainage
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
Chondroitin Sulfates
1
Accelerometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
toripalimab
×
90 days
×
Clear all
No trials found.